CTLA4 and cancer: The discovery of immune checkpoints, including cytotoxic T lymphocyte-associated protein-4 (CTLA-4) and programmed cell death protein-1 (PD-1, also known as PDCD1), was crucial to the development of cancer immunotherapy and has brought revolutionary changes [35,36].